Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.49 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.49 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.49 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.49 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21582232 | 1.00 | PRKCA (0.56) | PRKCADGKALPAR1ENPP2LPAR4 | |
| SCHEMBL21582230 | 1.00 | PRKCA (0.56) | PRKCADGKALPAR1ENPP2LPAR4 | |
| SCHEMBL23391257 | 0.96 | MGLL (0.53) | PRKCA | |
| SCHEMBL23391258 | 0.96 | MGLL (0.53) | PRKCA | |
| SCHEMBL5372668 | 0.92 | DGKA (0.53) | PRKCADGKAPRKCD | |
| SCHEMBL5369426 | 0.92 | DGKA (0.53) | PRKCADGKAPRKCD | |
| SCHEMBL5372816 | 0.90 | PRKCA (0.50) | PRKCADGKAPRKCD | |
| SCHEMBL21585313 | 0.90 | PRKCA (0.54) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL23198759 | 0.86 | MGLL (0.51) | PRKCAPRKCE | |
| SCHEMBL22602588 | 0.86 | MGLL (0.51) | PRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12152046-B2 | Oleic acid derivatives, pharmaceutical composition or food composition comprising said oleic acid derivatives, and their uses | UNIVERSITÉ DE BOUROGNE (FR) | 2024-11-26 | — | — | US | disclosed |
| US-20210238209-A1 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | EKTAH (FR) | 2021-08-05 | — | — | US | disclosed |
| US-20210238209-A1 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | EKTAH (FR) | 2021-08-05 | — | — | US | disclosed |
| EP-3801491-A1 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | Université de Bourgogne (FR) | 2021-04-14 | — | — | EP | disclosed |
| WO-2019228994-A1 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | Université de Bourgogne (FR) | 2019-12-05 | — | — | WO | disclosed |
| WO-2019228994-A1 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | Université de Bourgogne (FR) | 2019-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238209-A1 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | FFAR3, FFAR2, FFAR1 | PRKCA 1075/4885DGKA 318/4885LPAR1 39/4885 |
| US-12152046-B2 | Oleic acid derivatives, pharmaceutical composition or food composition comprising said oleic acid derivatives, and their uses | FFAR3, FFAR2, FFAR1 | PRKCA 1075/4885DGKA 318/4885LPAR1 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.